In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Biotinum Drug Master File in Korea (Biotinum KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Biotinum. The MFDS reviews the Biotinum KDMF as part of the drug registration process and uses the information provided in the Biotinum KDMF to evaluate the safety and efficacy of the drug.
After submitting a Biotinum KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Biotinum API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Biotinum suppliers with KDMF on PharmaCompass.